Drug Shortage Report for AURO-OLANZAPINE ODT
Report ID | 56352 |
Drug Identification Number | 02448750 |
Brand name | AURO-OLANZAPINE ODT |
Common or Proper name | OLANZAPINE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 3X10 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-07-25 |
Estimated end date | 2022-02-10 |
Actual end date | 2022-01-07 |
Shortage status | Resolved |
Updated date | 2022-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-24 | English | Compare |
v2 | 2018-07-24 | French | Compare |
v3 | 2018-07-26 | English | Compare |
v4 | 2018-09-28 | English | Compare |
v5 | 2018-09-28 | French | Compare |
v6 | 2018-10-03 | English | Compare |
v7 | 2018-10-03 | French | Compare |
v8 | 2018-10-12 | English | Compare |
v9 | 2018-10-12 | French | Compare |
v10 | 2018-11-13 | English | Compare |
v11 | 2018-11-13 | French | Compare |
v12 | 2018-11-13 | English | Compare |
v13 | 2018-11-13 | French | Compare |
v14 | 2018-12-21 | English | Compare |
v15 | 2018-12-21 | French | Compare |
v16 | 2019-01-14 | English | Compare |
v17 | 2019-01-14 | French | Compare |
v18 | 2019-01-24 | English | Compare |
v19 | 2019-01-24 | French | Compare |
v20 | 2020-05-22 | English | Compare |